Royalty Report: Medical, Delivery, Device – Collection: 240465


Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 4


This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 4

Primary Industries

  • Medical
  • Delivery
  • Device

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 240465

License Grant
The Irish Licensor hereby grants to Licensee for the Term, and Licensor hereby accepts,

(i)  an exclusive license of the Licensor Intellectual Property and the Joint Intellectual Property in connection with the applications or deliveries of compounds listed, except with respect to any Retained Licensor Intellectual Property, as to which Licensee is being granted a non-exclusive license
(ii) a non-exclusive license of the Licensor Intellectual Property and the Joint Intellectual Property in connection with the applications or deliveries of compounds listed on Appendix E, and
(iii) subject to existing contractual rights of third parties, an exclusive license of the Licensor Intellectual Property and the Joint Intellectual Property for use with any other compounds not listed on Appendices D or E and which are not Licensor Compounds.  

In each case for use only as Auto-Injector Technology and in the Field for the Territory to develop, make, have made, manufacture, have manufactured, package, use, import, export, promote, distribute, market, offer for sale, and sell the Devices and Products in the Field for the Territory.

License Property
Device shall mean any device or any parts or components thereof, the manufacture, use, importation or sale of which is covered by or embodies the Auto-Injector Technology, the Licensor Intellectual Property, the Joint Intellectual Property and the Licensee Intellectual Property.

Auto-Injector Technology shall mean any technology incorporated or used in a device (i) constituting a disposable, single use, needle injection system wherein the active ingredient is housed in a vial which is situated in a manner substantially perpendicular to the body surface, (ii) utilizing gas generation achieved via a chemical reaction for delivery of the active ingredient and (iii) having infusion time for delivery of an active ingredient which is less than or equal to 10 seconds. For the  avoidance of doubt, Auto-Injector Technology shall not include any other technology that does not meet the foregoing definition, whether or not similar or containing elements of the Licensor Intellectual Property, including, without limitation, the Medipad(TM) Technology or any other Excluded Technology.

Field of Use
Field shall mean the practice of delivering therapeutic entities utilizing Auto Injector Technology, other than (A) active ingredients used in the treatment of  (i) central nervous system disorders, (ii) pain, (iii) male erectile dysfunction, and (iv) gene therapy and gene delivery and (B) Licensor Compounds, provided, in the case of Licensor Compounds that Licensee has not previously sub- licensed the right to use the Auto-Injector Technology with respect to such compound to an unaffiliated third party on an exclusive basis pursuant to a written agreement and that Licensee has delivered to Licensor prior written notice of same.

IPSCIO Record ID: 204344

License Grant
Pursuant to the terms of a previous agreement, the Parties have agreed to cooperate in the development and marketing of a drug Product that includes a Device as part of the Product.

Per this agreement, in the case of inventions jointly made by the Parties that relate to Devices, the  Joint Inventions, Licensee shall have the right without the consent of Licensor to license or sublicense such Joint Inventions, and in the case of any invention made solely by Licensor, an Licensor Invention, Licensee shall have a nonexclusive license to such Licensor Invention.   The Parties have each granted to the other all licenses to patents, know-how or other intellectual property necessary for the performance of the Parties obligations under this Agreement.

License Property
Licensor is developing Compound(s) for the prevention and treatment of diabetes and obesity and potentially other indications.

The Device means a mechanical injection pen for daily use, including any components thereof and all associated labeling and packaging components, individually or incorporated into sub-assemblies, which meets the applicable Specifications, and is assembled with a pre-filled cartridge containing Compound and uses Licensee’s Infinity pen platform, including improvements thereto as from time to time incorporated into the applicable Specifications.

Field of Use
The use if for the prevention and treatment of diabetes and obesity and potentially other indications.

IPSCIO Record ID: 164315

License Grant
The Irish Licensor grants the Licensee of Bermuda an exclusive license to the Licensors Technology for all research, development, and commercial purposes solely in the Field, but not beyond the Field.

Licensor grants the Licensee a non-exclusive license, or, if applicable, sublicense, to use the Licensors Trademarks, upon or in relation to the promotion, marketing, advertising, sale or offering for sale of the Licensors Royalty Products.

License Property
The trademark license includes Medipad(TM) and Elan(R).

The Licensors Medipad System Patent Portfolio includes, among others, patents and applications for Method and Device for Entrapping a Volume of Gas in a Liquid Drug Container,  Improved Method of Packaging a Drug Delivery Kit,  Cartridge-Based Drug Delivery Device and Medicament Delivery Device.

Medipad/TM/ is a lightweight, disposable drug delivery system, which combines the simplicity of a patch with the extensive delivery capabilities of an infusion pump.

Field of Use
The field of use is for the research, development, and commercialization of Iron chelating agents and the Substitute Compounds.

IPSCIO Record ID: 248285

License Grant
The Norwegian Licensor hereby grants Licensee an exclusive (even as to Licensor) license to and under the Licensor Know-How, the Licensor Patents, the Licensor Trademarks and the Licensor Additional Intellectual Property (i) to use, sell, offer for sale, have sold and import the Product in the Licensed Territory; and (ii) to make or have made the Product anywhere in the world solely for such permitted use, sale, offer for sale and importation in the Licensed Territory.
License Property
Device means a nasal device used for the delivery of pharmaceutical products in a powder or liquid formulation and that is covered by an Licensor Patent listed below.

6,715,485 – Nasal delivery device
8,327,844 – Nasal delivery method
7,740,014 – Nasal devices

Product(s) means any products or product candidates developed by or under the authority of a Party or any of its Affiliates as of the Effective Date or during the Term consisting of a formulation that contains [as its sole active ingredient] a compound within the class of compounds [known as triptans], including any salt, polymorphic or amorphous form of such a compound, that is delivered in a nasal delivery device; [provided that, the foregoing definition of Product may be amended and expanded by the mutual agreement of the Parties, in each Partys sole discretion, to include a formulation of triptan with one or more other active ingredients]. For purposes of the foregoing, the class of compounds known as [triptans] includes the compounds known as of the Effective Date as the following Sumatriptan[, rizatriptan, naratriptan, zolmitriptan, almotriptan, frovatriptan, avitriptan and eletriptan]. Solely for the purposes of a Product shall also include products or product candidates consisting of [ a formulation that contains a compound within the class of compounds known as triptans (including any salt, polymorphic or amorphous form of such a compound) together with one or more other active ingredients, that is delivered in a nasal delivery device].  

Licensor Trademarks means, any, whether domestic or foreign, trademarks, service marks, and trade names Controlled by Licensor or any of its Affiliates as of the Effective Date or during the Term that are used (or required to be used) in connection with the Device or a Product in the Licensed Territory, including those trademarks, service marks and trade names listed (the 'Existing Licensor Trademarks').  
Service marks and trade names
Optimist, Optimose, Breath Powered, Bi-Directional

Field of Use
The rights granted apply to the healthcare industry relating to pharmaceutical products.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.